Literature DB >> 2989947

Distribution and function of peripheral alpha-adrenoceptors in the cardiovascular system.

R R Ruffolo.   

Abstract

alpha-Adrenoceptors may be subdivided based on their anatomical distribution within the synapse. Presynaptic alpha-adrenoceptors are generally of the alpha 2-subtype and modulate neurotransmitter liberation via a negative feedback mechanism. Postsynaptic alpha-adrenoceptors are usually of the alpha 1-subtype and mediate the response of the effector organ. Although this "anatomical" subclassification is generally applicable, many exceptions exist. A more useful classification of alpha-adrenoceptor subtypes is based on a pharmacological characterization in which selective agonists and antagonists are used. Peripheral alpha-adrenoceptors are critical in the regulation of the cardiovascular system. Postsynaptic alpha-adrenoceptors in arteries and veins represent a mixed population of alpha 1/alpha 2-adrenoceptors, with both subtypes mediating vasoconstriction. In the peripheral arterial circulation, postsynaptic vascular alpha 1-adrenoceptors are found in the adrenergic neuroeffector junction, whereas postsynaptic vascular alpha 2-adrenoceptors are located extrajunctionally. In the venous circulation, it appears that alpha 2-adrenoceptors may be predominantly junctional, whereas alpha 1-adrenoceptors may be predominantly extrajunctional. It has been proposed that junctional alpha-adrenoceptors will respond predominantly to norepinephrine liberated from sympathetic neurons, whereas extrajunctional alpha-adrenoceptors likely respond to circulating catecholamines. The functional role of extrajunctional alpha-adrenoceptors may be more important in disease states such as hypertension and congestive heart failure where circulating levels of catecholamines may be high and contribute to the maintenance of elevated vascular resistance. alpha 2-Adrenoceptors are also associated with the intima and may play a role in the release of an endogenous relaxing factor from the endothelium.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989947     DOI: 10.1016/0091-3057(85)90535-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  18 in total

1.  Topical combinations to treat microvascular dysfunction of chronic postischemia pain.

Authors:  André Laferrière; Rachid Abaji; Cheng-Yu Mark Tsai; J Vaigunda Ragavendran; Terence J Coderre
Journal:  Anesth Analg       Date:  2014-04       Impact factor: 5.108

2.  Alpha-1 and alpha-2 adrenoceptor agonists induce vasoconstriction of the normotensive rat caudal artery in vitro by stimulation of a heterogeneous population of alpha-1 adrenoceptors.

Authors:  J Atkinson; N Trescases; C Benedek; N Boillat; A K Fouda; F Krause; M C Pitton; C Rafizadeh; J C de Rivaz; M Sautel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

3.  Mechanisms of chronotropic cardiac effects of alinidine and plasma concentration-response relationships in the conscious dog with chronic atrioventricular block.

Authors:  M Boucher; E Chapuy; M A Lefebvre; A Mignot; P Duchêne-Marullaz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

4.  Effects of medetomidine-midazolam-fentanyl IV bolus injections and its reversal by specific antagonists on cardiovascular function in rabbits.

Authors:  Christine Baumgartner; Melanie Bollerhey; Johanna Ebner; Tibor Schuster; Julia Henke; Wolf Erhardt
Journal:  Can J Vet Res       Date:  2010-10       Impact factor: 1.310

5.  Effects of ketamine-xylazine intravenous bolus injection on cardiovascular function in rabbits.

Authors:  Christine Baumgartner; Melanie Bollerhey; Johanna Ebner; Lién Laacke-Singer; Tibor Schuster; Wolf Erhardt
Journal:  Can J Vet Res       Date:  2010-07       Impact factor: 1.310

6.  Epigenetic regulation of human alpha1d-adrenergic receptor gene expression: a role for DNA methylation in Sp1-dependent regulation.

Authors:  Gregory A Michelotti; D Marshall Brinkley; Daniel P Morris; Michael P Smith; Raphael J Louie; Debra A Schwinn
Journal:  FASEB J       Date:  2007-03-23       Impact factor: 5.191

7.  Prior iontophoresis of saline enhances vasoconstriction to phenylephrine and clonidine in the skin of the human forearm.

Authors:  Peter D Drummond
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

8.  Adrenergic receptors and the regulation of vascular resistance in bullfrog tadpoles (Rana catesbeiana).

Authors:  P B Kimmel
Journal:  J Comp Physiol B       Date:  1992       Impact factor: 2.200

9.  Greater vasodepressor sensitivity to nicardipine in spontaneously hypertensive rats (SHR) compared to normotensive rats.

Authors:  J Atkinson; M Sautel; M Sonnay; J P Fluckiger; J C de Rivaz; N Boillat; M C Piton; P A Porchet; J M Armstrong; A K Fouda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-04       Impact factor: 3.000

10.  Adrenomedullary function, obesity and permissive influences of catecholamines on body mass in patients with chromaffin cell tumours.

Authors:  Yaxin An; Manja Reimann; Jimmy Masjkur; Katharina Langton; Mirko Peitzsch; Timo Deutschbein; Martin Fassnacht; Natalie Rogowski-Lehmann; Felix Beuschlein; Stephanie Fliedner; Anthony Stell; Aleksander Prejbisz; Andrzej Januszewicz; Jacques Lenders; Stefan R Bornstein; Graeme Eisenhofer
Journal:  Int J Obes (Lond)       Date:  2018-03-03       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.